Vycor Medical (VYCO) Net Income towards Common Stockholders (2010 - 2026)
Vycor Medical (VYCO) posted quarterly Net Income towards Common Stockholders of -$142077.0 for Q1 2026, up 29.23% year-over-year from -$109944.4 in Q1 2025, and down 126.65% quarter-over-quarter from -$62686.0 in Q4 2025.
Vycor Medical (VYCO) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has reported Net Income towards Common Stockholders for 17 consecutive years, with -$142077.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders rose 29.23% year-over-year to -$142077.0; the TTM figure through Mar 2026 stood at -$338125.0 (up 23.07% YoY), while the FY2025 annual figure was -$396796.0, up 8.06% from the prior year.
- Net Income towards Common Stockholders slipped to -$142077.0 in Q1 2026 per VYCO's latest filing, from -$62686.0 in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $68406.0 in Q2 2023 and bottomed at -$276992.0 in Q3 2022.
- Historically, Net Income towards Common Stockholders has averaged -$123164.2 across 5 years, with a median of -$142077.0 in 2026.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders plunged 956.22% — and 2025, when it soared 337.97%.
- Vycor Medical's Net Income towards Common Stockholders stood at -$116548.0 in 2022, then gained by 20.16% to -$93055.0 in 2023, then surged by 92.76% to -$6737.0 in 2024, then sank by 830.47% to -$62686.0 in 2025, then sank by 126.65% to -$142077.0 in 2026.
- Business Quant data shows VYCO's Net Income towards Common Stockholders at -$142077.0 in Q1 2026, -$62686.0 in Q4 2025, and -$157249.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | -22,288.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -142,077.00 |
| Dec 31, 2025 | -62,686.00 |
| Sep 30, 2025 | -157,249.00 |
| Jun 30, 2025 | 23,887.00 |
| Mar 31, 2025 | -200,748.00 |
| Dec 31, 2024 | -6,737.00 |
| Sep 30, 2024 | -222,002.00 |
| Jun 30, 2024 | -10,038.00 |
| Mar 31, 2024 | -192,793.00 |
| Dec 31, 2023 | -93,055.00 |
| Sep 30, 2023 | -214,089.00 |
| Jun 30, 2023 | 68,406.00 |
| Mar 31, 2023 | -155,323.00 |
| Dec 31, 2022 | -116,548.00 |
| Sep 30, 2022 | -276,992.00 |
| Jun 30, 2022 | -99,010.00 |
| Mar 31, 2022 | -236,737.00 |
| Dec 31, 2021 | -187,062.00 |
| Sep 30, 2021 | -158,492.00 |
| Jun 30, 2021 | -9,374.00 |